Emerging options in the management of myocardial ischemia
- 27 January 1994
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 73 (3) , A18-A27
- https://doi.org/10.1016/0002-9149(94)90270-4
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarctionPublished by Elsevier ,1992
- Role of superoxide radicals in anoxia and reoxygenation-mediated vascular contractionLife Sciences, 1991
- The pharmacology of aspirin, heparin, coumarin, and thrombolytic agents. Implications for therapeutic use in cardiopulmonary disease.Chest, 1991
- Endothelial, platelet and leukocyte interactions in ischemic heart disease: Insights into potential mechanisms and their clinical relevanceJournal of the American College of Cardiology, 1990
- Aspirin in myocardial ischemia: Why, when, and how much?Clinical Cardiology, 1989
- Neutrophil function in ischemic heart disease.Circulation, 1989
- Coronary Angioscopy in Patients with Unstable Angina PectorisNew England Journal of Medicine, 1986
- Association between leukocyte count and the presence and extent of coronary atherosclerosis as determined by coronary arteriographyThe American Journal of Cardiology, 1984
- Some lessons in cardiovascular epidemiology from FraminghamThe American Journal of Cardiology, 1976
- The Leukocyte Count as a Predictor of Myocardial InfarctionNew England Journal of Medicine, 1974